间歇性肺炎的微环境促进了中枢淋巴结和肺部的转移
Ryo Maeda1, Mayu Inomata1, Ryusei Yamada1
1Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Frontiers in oncology
|October 30, 2025
概括
间歇性肺病 (ILD) 的肺环境促进了肺癌的转移. 皮尔芬尼 (PFD) 可能为ILD肺癌患者提供治疗策略.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 翻译医学是一种翻译医学.
背景情况:
- 患有肺癌和间歇性肺病 (ILD) 的患者的预后较差.
- 在ILD存在的情况下,肺癌的治疗选择有限.
- ILD肺环境对肺癌进展的影响尚不清楚.
研究的目的:
- 调查ILD肺环境是否影响肺癌的生物行为和进展.
- 用小鼠模型和临床数据来测试假设.
主要方法:
- 在实验室中使用了一种间歇性肺炎 (IP) 和肺癌的小鼠模型.
- 布莱米被用于诱导小鼠的IP.
- 建立了正位素肺癌模型.
- 分析了具有和没有ILD的肺癌患者的临床数据.
- 皮尔芬尼 (PFD) 用于治疗IP肺环境.
主要成果:
- IP肺环境显著促进了肺癌转移到淋巴结和逆侧肺部的转移.
- 临床数据证实ILD肺癌患者的血管入侵,淋巴透和转移的增加.
- 在IP肺癌模型中,使用PFD的药理治疗抑制了瘤进展.
结论:
- 这些发现表明,IP肺环境积极促进肺癌转移.
- 皮尔芬尼 (PFD) 显示出作为ILD肺癌治疗剂的潜力.
- 进一步的临床研究是有必要的,以评估PFD,单独或与化疗,对于这个患者群体.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


